Group 1 - The core viewpoint of the article highlights the launch of a new oral flea and tick treatment for dogs, FRONTPRO, by Boehringer Ingelheim in China, addressing the growing demand for pet health management as pet ownership increases [1][2] - The product, FRONTPRO, is designed to be administered once a month and effectively treats multiple external parasites, including fleas, ticks, and mites, with a palatable beef-flavored chewable form [2] - The increasing importance of pets in urban households has led to a higher demand for convenient and effective pet care solutions, as traditional deworming methods often face compliance issues among pet owners [1][2] Group 2 - Boehringer Ingelheim, founded in 1885, is a major global pharmaceutical company with a diverse product portfolio that includes human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing [2] - The company's recent half-year report indicates a 6.3% year-on-year increase in net sales, reaching €14 billion, with the animal health segment growing by 7.6% to €2.6 billion [2]